Ligand validation:4UXZ

79M: (2R)-2,3-dihydroxypropyl (7Z)-hexadec-7-enoate

79M is a Ligand Of Interest in 4UXZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4UXZ_79M_C_1122	28%	90%	0.213	0.866	0.25	0.35	-	-	4	0	100%	1
4UXZ_79M_B_1123	16%	90%	0.242	0.813	0.25	0.37	-	-	2	0	100%	1
4UXZ_79M_D_1124	11%	91%	0.225	0.737	0.27	0.31	-	-	1	0	100%	1
4UXZ_79M_A_1126	11%	93%	0.247	0.759	0.22	0.26	-	-	3	0	100%	1
4UXZ_79M_B_1121	3%	93%	0.296	0.65	0.22	0.26	-	-	0	0	100%	1
4UXZ_79M_B_1122	3%	91%	0.354	0.675	0.26	0.32	-	-	1	0	100%	1
4UXZ_79M_A_1125	2%	89%	0.319	0.587	0.22	0.4	-	-	2	0	100%	1
4BRR_79M_D_1125	29%	96%	0.203	0.862	0.19	0.16	-	-	0	0	100%	1
4UYO_79M_B_1124	17%	91%	0.243	0.824	0.24	0.34	-	-	2	0	100%	1
7CQM_79M_A_314	77%	71%	0.096	0.934	0.5	0.62	-	-	1	0	100%	1
5OC9_79M_B_709	29%	93%	0.251	0.909	0.22	0.24	-	-	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.